Dr. Howard Goldman

Urology

MD, FACS, Professor and Vice Chair (Quality and Patient Safety), Glickman Urologic and Kidney Institute, Cleveland Clinic Lerner College of Medicine, USA

United States of America

Publications Featured in

Publications

Selected publications from PubMed

A Global Consensus Conference on Surgical Management of Primary Uterovaginal Prolapse and Lower Urinary Tract Dysfunction: Combining Evidence with Expert Opinion.

Gupta A, Grimes CL, Badlani G, Bortolini MAT, Rosamilia A, Robinson D, Nitti V, Cameron A, Deprest J, Sisson A, Tan YH, Goldman HB, Cundiff GW, Alperin M, El Haraki A, Collins S, Hegde A, Kyaw HY, Rotem R, Quiroz L, Sokol E, Brennand EA, Woodburn K, Lallemant M, Ferrando C, Van Eijndhoven H, Baekelandt J, Ashmore S, Kenton K, Kang K, Matthews CA, U-POP Consortium

Int Urogynecol J. 2026 Jul 2 doi: 10.1007/s00192-026-06758-6.

Urinary Microbiome and Metabolome Differentiate Overactive Bladder From the Physiological State, and Reflect Recent Antibiotic Use and Treatment Response.

Werneburg GT, Gross MD, Hettel DR, Lyon M, Jeong SH, McSweeney S, Knorr JM, Adler A, Dang T, Orji P, Ramanujan S, Goldman HB, Vasavada SP, Miller AW

J Urol. 2026 Jul;216(1):78-88 doi: 10.1097/JU.0000000000004990.

Polypropylene mesh degradation and systemic disease: biological plausibility is not clinical evidence.

Chughtai B, Polo J, Goldman HB

Nat Rev Urol. 2026 Jun 2 doi: 10.1038/s41585-026-01158-3.

Urinary Fungal Microbiome and Associations With Overactive Bladder, Antibiotics and Therapy Response.

Werneburg GT, Gross MD, Hettel DR, Lyon M, McSweeney S, Jeong SH, Knorr JM, Adler A, Dang T, Orji P, Ramanujan S, Slopnick E, Goldman HB, Vasavada SP, Miller AW

Neurourol Urodyn. 2026 Mar;45(3):435-445 doi: 10.1002/nau.70227.

Validation of a Wireless Catheter-Free Ambulatory Urodynamics Device in Women With Neurogenic Bladder.

Gross MD, Frainey BT, Lyon ME, Lewis KC, Elazab M, Bukhari HA, Tevis T, Butler RS, Burhanna R, Smith C, Goldman HB, Hoang-Roberts L, Damaser MS, Majerus SJA

Neurourol Urodyn. 2026 Jan;45(1):96-104 doi: 10.1002/nau.70172.

Featured in

2h 27min

Sacral Neuromodulation for Bladder and Bowel Management

Fecal incontinence and Overactive Bladder are very prevalent disabling disorders. A plethora of therapeutic options have been attempted without universal acceptance due to suboptimal results. Sacral neuromodulation (SNM) has become widely globally accepted as a very effective safe option for the treatment of both fecal incontinence and overactive bladder. In addition, this technology is the only practical therapy that can treat Idiopathic Urinary Retention. This program combines the expertise of both colorectal surgeons and urologists to share their expertise and insights about the role of SNM within the spectrum of available therapeutic options for these conditions. Optimal outcomes in both high and low-resource environments will be described and best practice methods to help ensure maximum efficacy will be evaluated.

With Medtronic

Published

Dec 2023

Share this expert

Help your network discover Dr. Howard Goldman's clinical expertise.